JCVI issues advice on third dose COVID-19 vaccination for severely immunosuppressed

Share on facebook
Share on twitter
Share on linkedin
The Joint Committee on Vaccination and Immunisation (JCVI) is advising that people with severely weakened immune systems should have a third vaccine dose as part of their primary COVID-19 vaccination schedule.
Glass Medicine Vials and Syringe

New announcement from JCVI on people who are severely immunosuppressed and third doses of COVID-19 vaccine. This is recommending a third dose as part of the primary vaccination, at least 8 weeks after the second dose. Others will get a third booster dose when the booster programme is rolled out.

Looking at the definition of severely immunosuppressed this will include some people with inflammatory conditions who were on a range of immunosuppressing treatment within 3 months (or in some cases 6 months) of their vaccination. For the detail of who is included, see points 2, 3 and 4 of the notes to editors.

Read the full announcement here